Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Pancreatic Cancer Diagnostic Revenue 1.4 Market Analysis by Type 1.4.1 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Imaging 1.4.3 Tumor Biomarker 1.4.4 Biopsy 1.4.5 Other 1.5 Market by Application 1.5.1 Global Pancreatic Cancer Diagnostic Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Pancreatic Cancer Diagnostic Market Perspective (2015-2026) 2.2 Pancreatic Cancer Diagnostic Growth Trends by Regions 2.2.1 Pancreatic Cancer Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Pancreatic Cancer Diagnostic Historic Market Share by Regions (2015-2020) 2.2.3 Pancreatic Cancer Diagnostic Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Pancreatic Cancer Diagnostic Market Growth Strategy 2.3.6 Primary Interviews with Key Pancreatic Cancer Diagnostic Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Pancreatic Cancer Diagnostic Players by Market Size 3.1.1 Global Top Pancreatic Cancer Diagnostic Players by Revenue (2015-2020) 3.1.2 Global Pancreatic Cancer Diagnostic Revenue Market Share by Players (2015-2020) 3.1.3 Global Pancreatic Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Pancreatic Cancer Diagnostic Market Concentration Ratio 3.2.1 Global Pancreatic Cancer Diagnostic Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Diagnostic Revenue in 2019 3.3 Pancreatic Cancer Diagnostic Key Players Head office and Area Served 3.4 Key Players Pancreatic Cancer Diagnostic Product Solution and Service 3.5 Date of Enter into Pancreatic Cancer Diagnostic Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Type (2015-2020) 4.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Type (2021-2026) 5 Pancreatic Cancer Diagnostic Breakdown Data by Application (2015-2026) 5.1 Global Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 5.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Pancreatic Cancer Diagnostic Market Size (2015-2020) 6.2 Pancreatic Cancer Diagnostic Key Players in North America (2019-2020) 6.3 North America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 6.4 North America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 7 Europe 7.1 Europe Pancreatic Cancer Diagnostic Market Size (2015-2020) 7.2 Pancreatic Cancer Diagnostic Key Players in Europe (2019-2020) 7.3 Europe Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 7.4 Europe Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 8 China 8.1 China Pancreatic Cancer Diagnostic Market Size (2015-2020) 8.2 Pancreatic Cancer Diagnostic Key Players in China (2019-2020) 8.3 China Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 8.4 China Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 9 Japan 9.1 Japan Pancreatic Cancer Diagnostic Market Size (2015-2020) 9.2 Pancreatic Cancer Diagnostic Key Players in Japan (2019-2020) 9.3 Japan Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 9.4 Japan Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Pancreatic Cancer Diagnostic Market Size (2015-2020) 10.2 Pancreatic Cancer Diagnostic Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 10.4 Southeast Asia Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 11 India 11.1 India Pancreatic Cancer Diagnostic Market Size (2015-2020) 11.2 Pancreatic Cancer Diagnostic Key Players in India (2019-2020) 11.3 India Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 11.4 India Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Pancreatic Cancer Diagnostic Market Size (2015-2020) 12.2 Pancreatic Cancer Diagnostic Key Players in Central & South America (2019-2020) 12.3 Central & South America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) 12.4 Central & South America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Roche 13.1.1 Roche Company Details 13.1.2 Roche Business Overview and Its Total Revenue 13.1.3 Roche Pancreatic Cancer Diagnostic Introduction 13.1.4 Roche Revenue in Pancreatic Cancer Diagnostic Business (2015-2020)) 13.1.5 Roche Recent Development 13.2 GE Healthcare 13.2.1 GE Healthcare Company Details 13.2.2 GE Healthcare Business Overview and Its Total Revenue 13.2.3 GE Healthcare Pancreatic Cancer Diagnostic Introduction 13.2.4 GE Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.2.5 GE Healthcare Recent Development 13.3 Siemens 13.3.1 Siemens Company Details 13.3.2 Siemens Business Overview and Its Total Revenue 13.3.3 Siemens Pancreatic Cancer Diagnostic Introduction 13.3.4 Siemens Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.3.5 Siemens Recent Development 13.4 BD 13.4.1 BD Company Details 13.4.2 BD Business Overview and Its Total Revenue 13.4.3 BD Pancreatic Cancer Diagnostic Introduction 13.4.4 BD Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.4.5 BD Recent Development 13.5 Philips Healthcare 13.5.1 Philips Healthcare Company Details 13.5.2 Philips Healthcare Business Overview and Its Total Revenue 13.5.3 Philips Healthcare Pancreatic Cancer Diagnostic Introduction 13.5.4 Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.5.5 Philips Healthcare Recent Development 13.6 Hitachi Medical 13.6.1 Hitachi Medical Company Details 13.6.2 Hitachi Medical Business Overview and Its Total Revenue 13.6.3 Hitachi Medical Pancreatic Cancer Diagnostic Introduction 13.6.4 Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.6.5 Hitachi Medical Recent Development 13.7 Danaher 13.7.1 Danaher Company Details 13.7.2 Danaher Business Overview and Its Total Revenue 13.7.3 Danaher Pancreatic Cancer Diagnostic Introduction 13.7.4 Danaher Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.7.5 Danaher Recent Development 13.8 Abbott 13.8.1 Abbott Company Details 13.8.2 Abbott Business Overview and Its Total Revenue 13.8.3 Abbott Pancreatic Cancer Diagnostic Introduction 13.8.4 Abbott Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.8.5 Abbott Recent Development 13.9 Canon Medical Systems 13.9.1 Canon Medical Systems Company Details 13.9.2 Canon Medical Systems Business Overview and Its Total Revenue 13.9.3 Canon Medical Systems Pancreatic Cancer Diagnostic Introduction 13.9.4 Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.9.5 Canon Medical Systems Recent Development 13.10 Myriad Genetics 13.10.1 Myriad Genetics Company Details 13.10.2 Myriad Genetics Business Overview and Its Total Revenue 13.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Introduction 13.10.4 Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 13.10.5 Myriad Genetics Recent Development 13.11 Qiagen 10.11.1 Qiagen Company Details 10.11.2 Qiagen Business Overview and Its Total Revenue 10.11.3 Qiagen Pancreatic Cancer Diagnostic Introduction 10.11.4 Qiagen Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 10.11.5 Qiagen Recent Development 13.12 Asuragen 10.12.1 Asuragen Company Details 10.12.2 Asuragen Business Overview and Its Total Revenue 10.12.3 Asuragen Pancreatic Cancer Diagnostic Introduction 10.12.4 Asuragen Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 10.12.5 Asuragen Recent Development 13.13 BioMarker Strategies 10.13.1 BioMarker Strategies Company Details 10.13.2 BioMarker Strategies Business Overview and Its Total Revenue 10.13.3 BioMarker Strategies Pancreatic Cancer Diagnostic Introduction 10.13.4 BioMarker Strategies Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) 10.13.5 BioMarker Strategies Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Pancreatic Cancer Diagnostic Key Market Segments Table 2. Key Players Covered: Ranking by Pancreatic Cancer Diagnostic Revenue Table 3. Ranking of Global Top Pancreatic Cancer Diagnostic Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Imaging Table 6. Key Players of Tumor Biomarker Table 7. Key Players of Biopsy Table 8. Key Players of Other Table 9. Global Pancreatic Cancer Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Pancreatic Cancer Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Pancreatic Cancer Diagnostic Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Pancreatic Cancer Diagnostic Market Share by Regions (2015-2020) Table 13. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Pancreatic Cancer Diagnostic Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Pancreatic Cancer Diagnostic Market Growth Strategy Table 19. Main Points Interviewed from Key Pancreatic Cancer Diagnostic Players Table 20. Global Pancreatic Cancer Diagnostic Revenue by Players (2015-2020) (Million US$) Table 21. Global Pancreatic Cancer Diagnostic Market Share by Players (2015-2020) Table 22. Global Top Pancreatic Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Diagnostic as of 2019) Table 23. Global Pancreatic Cancer Diagnostic by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Pancreatic Cancer Diagnostic Product Solution and Service Table 26. Date of Enter into Pancreatic Cancer Diagnostic Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 29. Global Pancreatic Cancer Diagnostic Market Size Share by Type (2015-2020) Table 30. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2021-2026) Table 31. Global Pancreatic Cancer Diagnostic Market Size Share by Application (2015-2020) Table 32. Global Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 33. Global Pancreatic Cancer Diagnostic Market Size Share by Application (2021-2026) Table 34. North America Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 35. North America Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 36. North America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 37. North America Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 38. North America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 39. North America Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 40. Europe Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 42. Europe Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 43. Europe Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 44. Europe Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 45. Europe Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 46. China Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 47. China Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 48. China Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 49. China Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 50. China Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 51. China Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 52. Japan Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 54. Japan Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 55. Japan Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 56. Japan Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 57. Japan Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 60. Southeast Asia Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 62. Southeast Asia Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 64. India Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 65. India Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 66. India Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 67. India Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 68. India Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 69. India Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 70. Central & South America Key Players Pancreatic Cancer Diagnostic Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Pancreatic Cancer Diagnostic Market Share (2019-2020) Table 72. Central & South America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Pancreatic Cancer Diagnostic Market Share by Type (2015-2020) Table 74. Central & South America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Pancreatic Cancer Diagnostic Market Share by Application (2015-2020) Table 76. Roche Company Details Table 77. Roche Business Overview Table 78. Roche Product Table 79. Roche Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 80. Roche Recent Development Table 81. GE Healthcare Company Details Table 82. GE Healthcare Business Overview Table 83. GE Healthcare Product Table 84. GE Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 85. GE Healthcare Recent Development Table 86. Siemens Company Details Table 87. Siemens Business Overview Table 88. Siemens Product Table 89. Siemens Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 90. Siemens Recent Development Table 91. BD Company Details Table 92. BD Business Overview Table 93. BD Product Table 94. BD Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 95. BD Recent Development Table 96. Philips Healthcare Company Details Table 97. Philips Healthcare Business Overview Table 98. Philips Healthcare Product Table 99. Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 100. Philips Healthcare Recent Development Table 101. Hitachi Medical Company Details Table 102. Hitachi Medical Business Overview Table 103. Hitachi Medical Product Table 104. Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 105. Hitachi Medical Recent Development Table 106. Danaher Company Details Table 107. Danaher Business Overview Table 108. Danaher Product Table 109. Danaher Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 110. Danaher Recent Development Table 111. Abbott Business Overview Table 112. Abbott Product Table 113. Abbott Company Details Table 114. Abbott Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 115. Abbott Recent Development Table 116. Canon Medical Systems Company Details Table 117. Canon Medical Systems Business Overview Table 118. Canon Medical Systems Product Table 119. Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 120. Canon Medical Systems Recent Development Table 121. Myriad Genetics Company Details Table 122. Myriad Genetics Business Overview Table 123. Myriad Genetics Product Table 124. Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 125. Myriad Genetics Recent Development Table 126. Qiagen Company Details Table 127. Qiagen Business Overview Table 128. Qiagen Product Table 129. Qiagen Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 130. Qiagen Recent Development Table 131. Asuragen Company Details Table 132. Asuragen Business Overview Table 133. Asuragen Product Table 134. Asuragen Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 135. Asuragen Recent Development Table 136. BioMarker Strategies Company Details Table 137. BioMarker Strategies Business Overview Table 138. BioMarker Strategies Product Table 139. BioMarker Strategies Revenue in Pancreatic Cancer Diagnostic Business (2015-2020) (Million US$) Table 140. BioMarker Strategies Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Pancreatic Cancer Diagnostic Market Share by Type: 2020 VS 2026 Figure 2. Imaging Features Figure 3. Tumor Biomarker Features Figure 4. Biopsy Features Figure 5. Other Features Figure 6. Global Pancreatic Cancer Diagnostic Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Others Case Studies Figure 10. Pancreatic Cancer Diagnostic Report Years Considered Figure 11. Global Pancreatic Cancer Diagnostic Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Pancreatic Cancer Diagnostic Market Share by Regions: 2020 VS 2026 Figure 13. Global Pancreatic Cancer Diagnostic Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Pancreatic Cancer Diagnostic Market Share by Players in 2019 Figure 16. Global Top Pancreatic Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Diagnostic as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Cancer Diagnostic Revenue in 2019 Figure 18. North America Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Roche Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 27. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. GE Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 29. Siemens Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Siemens Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 31. BD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. BD Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 33. Philips Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Philips Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 35. Hitachi Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Hitachi Medical Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 37. Danaher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Danaher Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 39. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Abbott Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 41. Canon Medical Systems Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Canon Medical Systems Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 43. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Myriad Genetics Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 45. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Qiagen Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 47. Asuragen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Asuragen Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 49. BioMarker Strategies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. BioMarker Strategies Revenue Growth Rate in Pancreatic Cancer Diagnostic Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Roche GE Healthcare Siemens BD Philips Healthcare Hitachi Medical Danaher Abbott Canon Medical Systems Myriad Genetics Qiagen Asuragen BioMarker Strategies